Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Short-seller Muddy Waters takes aim at Nano-X Imaging after Citron

Published 09/22/2020, 09:30 AM
Updated 09/22/2020, 09:35 AM
©  Reuters

© Reuters

(Reuters) - U.S.-listed shares of Israel's Nano-X Imaging Ltd (O:NNOX) fell nearly 20% on Tuesday after short-seller Muddy Waters (NYSE:WAT) joined Citron Research in raising doubts over the company's diagnostic product.

Muddy Waters likened the company to Nikola Corp (O:NKLA), whose founder Trevor Milton stepped down on Monday amid scathing reports from short-sellers.

"We conclude that NNOX (Nano-X) has no real product to sell other than its stock," Muddy Waters said in a report on Tuesday.

Nano-X Imaging did not immediately respond to a Reuters request for comment.

Shares in Nano-X Imaging, which had been on an upward run since their market debut in August, took a hit last week after Citron said the stock was headed towards $0 and called the company a "stock promotion".

Citron's comments focused on the company's Nanox System, which comprises a digital X-ray device and cloud-based software that will be designed to provide an end-to-end medical imaging service.

The company had said Citron's allegations were without merit and it would provide information on the report "as appropriate".

Its shares were down 19.2% to $23.3 before the opening bell on Tuesday.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.